PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Demonstrating Value Created by In-Silico Solutions to Help Maximise Virtual Screening Opportunities - Frost & Sullivan finds that Virtual Screening Opportunities in Drug Discovery in Europe generated revenues of $93.2 million in 2006 and estimates this to reach $228.4 million in 2013
Demonstrating Value Created by In-Silico Solutions to Help Maximise Virtual Screening Opportunities

 

NewswireToday - /newswire/ - London, United Kingdom, 2007/02/14 - Frost & Sullivan finds that Virtual Screening Opportunities in Drug Discovery in Europe generated revenues of $93.2 million in 2006 and estimates this to reach $228.4 million in 2013.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Suppliers in the highly competitive and fragmented European virtual screening market face challenges such as limited scientific audience and the lack of common technology standards. Also, despite the high demand for software tools, companies need to develop and introduce the right kind of tools and solutions to broaden their customer base. The key to success will be to demonstrate to customers the value that can be created by proper implementation of in-silico solutions.

Frost & Sullivan (healthcare.frost.com) finds that Virtual Screening Opportunities in Drug Discovery in Europe generated revenues of $93.2 million in 2006 and estimates this to reach $228.4 million in 2013.

Increasing economic pressure on the pharmaceutical industry to develop new drugs in a faster, efficient and more economic way than in the past has led to the emergence of several new methods aimed at a more efficient and rapid lead structure discovery process.

"Recent advances in combinatorial chemistry have made it possible to synthesise large libraries of compounds, and high throughput screening (HTS) provides a considerable reduction of the time needed for the discovery of new molecules possessing biological activity for a certain target," comments Frost & Sullivan Drug Discovery Team Leader Dr. Amarpreet Dhiman. "With experimental efforts to carry out the biological screening of billions of compounds still high, computational techniques and computer-aided drug design approaches have emerged as promising tools in helping researchers decide what to screen and synthesise."

Most pharmaceutical companies now have access to models that seek to predict key properties of the chemical structures that their research teams plan to synthesise. These range from the simple application of the ubiquitous Lipinski's rule of five, to the relatively sophisticated integration and scoring of a range of predictive models. While the rising use of predictive in-silico models is encouraging, much research remains to be performed to demonstrate appropriate confidence in the output of currently developed models and broaden the chemistry space covered.

In the drug development process, the data most readily available is that which concerns efficacy and selectivity. Often, at this point, researchers will transfer the compound to a preclinical stage using animal models, where the data becomes less consistent from study to study.

To create the most accurate predictive models, software developers need to have access to accurate and consistent data, so that they can model interstudy variations and reduce those variations to key characteristics. However, for a number of reasons, information from different laboratories is often not compatible, and thus a reasonable amount of consistent data is needed to build better models.

"Many companies are using in-silico techniques, but there is concern that these models are causing promising compounds to be disregarded based on in-silico model results," adds Dr. Dhiman. "This is resulting is some scepticism and uncertainty in the acceptance of these tools."

Informatics applications for toxicity screening is an area requiring further development and proof of concept studies, as confidence among researchers remains limited. Companies are very sceptical about the reliability of these models compared to actual experimentation. The prediction that in-silico models would replace in vivo and in vitro testing is yet to be fulfilled with current landscape favouring the belief that the best results will occur through a simultaneous use of all available tools.

"To allow companies to reap the benefits from in-silico studies, in the first instance, the data generated needs to be of high quality, reliable and accurate," advises Dr. Dhiman. "A key to achieving this objective would be to develop tools that facilitate data consolidation and information sharing; then systems would be standardised, allowing for solutions that integrate data from numerous tools and experiments."

Moreover, manufacturers should offer their services in data management, training and tool maintenance among others. They should function as both service provider and product developer. By partnering with clinical organisations, informatics and tool companies, manufacturers would be able to create solutions that best meet research needs.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis of the Virtual Screening Opportunities in Drug Discovery in Europe (M045 - 48), send an e-mail to Radhika Menon Theodore - Corporate Communications at rmtherodore[.]frost.com with your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information through email upon receipt of the above information.

Virtual Screening Opportunities in Drug Discovery in Europe is part of the Drug Discovery and Diagnostic Technologies Subscription, which also includes research in the following markets: Gene Expression Markets in Europe, Contract Research Organisations (CROs) Markets in Europe and Nucleic Acid Isolation Markets in Europe. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews are available to the press.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

Melina Trevino
Corporate Communications - Americas
P: +1-210-247-2440
F: +1-210-348-1003
E: melina.trevino[.]frost.com

Keywords in this release: virtual screening in drug discovery, virtual screening, drug discovery, market, Europe, software tools, in-silico solutions, pharmaceutical industry, drugs, lead structure discovery process, combinatorial chemistry, high throughput screening, HTS, biological screening, computational techniques, computer-aided drug design, Lipinski's rule of five, predictive in-silico models, drug development, animal models, predictive models, software developers, informatics applications, toxicity screening, proof of concept studies, in vivo, in vitro testing

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Demonstrating Value Created by In-Silico Solutions to Help Maximise Virtual Screening Opportunities

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Radhika Menon Theodore 
+91-44-42044541 rmtherodore[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Sparta Systems Broadens Partnership with TrackWise Implementation Specialist Equality Systems
Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)